Asthenozoospermia (Low Sperm Motility) Support Protocol

Asthenozoospermia is a condition where sperm have reduced motility (movement). Sperm need to swim effectively to reach and fertilize an egg. When motility is low, it reduces the chances of natural conception.

NORMAL SPERM MOTILITY:

•Progressive motility >32% OR

•Total motility (progressive + non-progressive) >40%

CAUSES:

•Often idiopathic (unknown cause)

•Varicocele (varicose veins in scrotum)

•Infections (past or present)

•Lifestyle factors (smoking, alcohol, heat exposure)

•Oxidative stress

•Nutritional deficiencies

•Genetic factors

•Certain medications

LIFESTYLE MODIFICATIONS:

•Stop smoking

•Limit alcohol

•Avoid excessive heat (hot tubs, saunas, laptop on lap)

•Maintain healthy weight

•Regular but not excessive exercise

•Wear loose-fitting underwear

•Manage stress

WHEN TO SEEK TREATMENT:

•After 12 months of trying (6 months if female partner >35)

•Semen analysis confirms asthenozoospermia

•Consider varicocele evaluation

MEDICAL TREATMENTS:

•Varicocele repair (if present)

•Treat underlying infections

•Assisted reproduction (IUI, IVF, ICSI)

* CoQ10 and L-carnitine are most studied for improving sperm motility.

* Zinc and selenium are essential for sperm function.

* Antioxidants protect sperm from oxidative damage.

Expected timeline: Sperm production takes ~74 days. Allow 3-6 months of supplementation before reassessing semen parameters.

Clinical Perspective

Asthenozoospermia: WHO criteria - progressive motility <32% or total motility <40%. Idiopathic when no identifiable cause. Causes: varicocele, infection, antisperm antibodies, environmental/lifestyle, medications, genetic. Workup: semen analysis, hormones (FSH, LH, testosterone), scrotal ultrasound for varicocele.

Treatment: Address correctable causes (varicocele repair, treat infection). Lifestyle modifications (smoking cessation, limit alcohol/heat, weight management). Antioxidants have best evidence among supplements (CoQ10, L-carnitine, zinc, selenium). If not improving, assisted reproduction (IUI, IVF, ICSI). Empiric supplement trial reasonable for 3-6 months before ART.

* CoQ10 (B-grade): Mitochondrial energy. Meta-analysis: (PMID: 24268541). 200-300mg daily.

* L-Carnitine (B-grade): Sperm metabolism. Meta-analysis: (PMID: 23597877). 2-3g daily.

* Zinc (B-grade): Essential mineral. Systematic review: (PMID: 26845419). 25-50mg daily.

* Selenium (B-grade): Selenoproteins. Meta-analysis: (PMID: 26845419). 100-200mcg daily.

* Omega-3 (C-grade): Membrane DHA. Review: (PMID: 27840029). 1-2g DHA daily.

* Vitamin E (C-grade): Antioxidant. Review: (PMID: 23075608). 400 IU daily.

* Folate (C-grade): DNA synthesis. Review: (PMID: 27450775). 400-800mcg daily.

Assessment targets: Semen analysis (motility, concentration, morphology), pregnancy rates.

Protocol notes: Semen analysis: wait 2-7 days abstinence; at least 2 samples (variability exists). Varicocele: present in ~40% of infertile men; repair can improve parameters. Oxidative stress: major factor in idiopathic cases; antioxidants address this. Time frame: spermatogenesis ~74 days; wait 3-6 months before reassessing. Combination: multiple antioxidants often used together. ART: IUI if mild; IVF for moderate; ICSI for severe asthenozoospermia. Heat: avoid hot baths, saunas, tight underwear, laptop on lap. Medications: review for gonadotoxins. Female factor: always evaluate partner simultaneously. Age: male factor increases with age but less dramatically than female.

View All Protocols